EcoDrugPlus

Cytidine Deaminase

Ensembl ID : ENSMOCG00000017541
Gene Symbol: CDA
3 Cross references
224 Possible Orthologues:

Cytochrome P450 26a1

Ensembl ID : ENSMOCG00000020487
Gene Symbol: LOC101991365
3 Cross references
207 Possible Orthologues:

Cytochrome P450 3a11-Like

Ensembl ID : ENSMOCG00000000780
Gene Symbol: LOC101994661
2 Cross references
635 Possible Orthologues:

Cytochrome P450 3a13-Like

Ensembl ID : ENSMOCG00000017736
Gene Symbol: LOC101996465
2 Cross references
622 Possible Orthologues:

Cytochrome P450 3a2-Like

Ensembl ID : ENSMOCG00000001369
Gene Symbol: LOC101996869
2 Cross references
635 Possible Orthologues:

Cytochrome P450 3a25

Ensembl ID : ENSMOCG00000015817
Gene Symbol: LOC101995535
2 Cross references
629 Possible Orthologues:

Cytochrome P450 3a9

Ensembl ID : ENSMOCG00000012531
Gene Symbol: LOC101996747
2 Cross references
627 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1

Ensembl ID : ENSMOCG00000017786
Gene Symbol: DGAT1
3 Cross references
260 Possible Orthologues:

Dihydrofolate Reductase

Ensembl ID : ENSMOCG00000014691
Gene Symbol: DHFR
3 Cross references
353 Possible Orthologues:

Dihydropyrimidine Dehydrogenase

Ensembl ID : ENSMOCG00000019630
Gene Symbol: DPYD
3 Cross references
220 Possible Orthologues:

Dipeptidyl Peptidase 4

Ensembl ID : ENSMOCG00000016136
Gene Symbol: DPP4
3 Cross references
282 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSMOCG00000021294
Gene Symbol: DDR2
3 Cross references
265 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).